Short Interest in Ascentage Pharma Group International (OTCMKTS:ASPHF) Decreases By 12.6%

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the target of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 368,100 shares, a drop of 12.6% from the September 15th total of 421,400 shares. Based on an average daily volume of 127,300 shares, the short-interest ratio is currently 2.9 days.

Ascentage Pharma Group International Price Performance

Shares of OTCMKTS ASPHF opened at $2.69 on Wednesday. The business’s 50 day moving average price is $2.69 and its two-hundred day moving average price is $2.65. Ascentage Pharma Group International has a twelve month low of $2.35 and a twelve month high of $3.63.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.